Shares of agilon health, Inc. (NYSE: AGL) fell more than 25% in after-hours trading on Monday, August 4, 2025, after the company announced that its CEO, president and director, Steven Sell, had stepped down effective immediately and that it was withdrawing its full-year 2025 financial guidance. The company attributed the move to unexpected medical cost pressures and downward adjustments to prior revenue estimates.
Contact our attorneys for a no-cost case evaluation.